BGM

Peers: CPIX CTOR SCYX SCLX DERM CRDL LFCR ADCT ANIK TKNO

Index	-
Market Cap	117.73M
Enterprise Value	108.89M
Income	-21.18M
Sales	47.90M
Book/sh	1.99
Cash/sh	0.03
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	471
IPO	Jan 12, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	2.46
P/B	0.14
P/C	10.19
P/FCF	80.64
EV/EBITDA	-
EV/Sales	2.27
Quick Ratio	0.65
Current Ratio	1.25
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-0.16
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	-16.38% -5.39%
EPS Y/Y TTM	43.63%
Sales Y/Y TTM	78.43%
EPS Q/Q	58.46%
Sales Q/Q	69.76%
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	72.42%
Insider Trans	0.00%
Inst Own	0.09%
Inst Trans	0.40%
ROA	-6.58%
ROE	-7.30%
ROIC	-5.32%
Gross Margin	12.81%
Oper. Margin	-23.42%
Profit Margin	-44.22%
SMA20	1.94%
SMA50	-2.67%
SMA200	-80.11%
Trades

Shs Outstand	180.62M
Shs Float	116.03M
Short Float	0.15%
Short Ratio	0.66
Short Interest	0.17M
52W High	11.80 -97.63%
52W Low	0.23 22.39%
Volatility	14.10% 14.85%
ATR (14)	0.03
RSI (14)	50.25
Beta	1.86
Rel Volume	0.12
Avg Volume	256.70K
Volume	22,819

Perf Week	2.49%
Perf Month	3.09%
Perf Quarter	-36.97%
Perf Half Y	-68.90%
Perf YTD	-92.41%
Perf Year	-96.59%
Perf 3Y	-92.73%
Perf 5Y	-98.58%
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	0.25
Price	0.28
Change %	13.23%

Feb-26-26 04:15PM	BGM Group Ltd. Receives NASDAQ Notice Related to Late Filing of Form 20-F (GlobeNewswire) +6.86%
Oct-01-25 01:41PM	BGM Group Ltd. (BGM) Surges 35% as AI, Biopharma Transformation Gains Investor Attention (Insider Monkey)
Jul-23-25 06:36AM	BGM To Report First Half 2025 Unaudited Financial Results on July 24, 2025 (PR Newswire)
May-28-25 04:30PM	From Virtual Agents to Embodied and Industry-Specific AI: BGM Acquires Xingdao Intelligent and YD Network, Advancing AI on Two Fronts (PR Newswire) -18.89% +20.35%
May-02-25 08:30AM	BGM Group Announces Strategic Acquisition of HM Management to Expand AI Application Ecosystem (PR Newswire)
08:30AM	Loading…
Apr-28-25 08:30AM	BGM Completes Acquisition of YX to Advance AI-Powered Intelligent Platform (PR Newswire)
Apr-21-25 08:30AM	BGM Group Acquires Wonder Dragon to Accelerate 'Healthcare' Strategy (PR Newswire)
Mar-19-25 08:30AM	BGM Acquires YX to Strengthen AI Strategy for Its Intelligent Platform (PR Newswire)
Feb-28-25 08:30AM	BGM Group Announces Board Reshuffle: New Leadership Embarks on a Transformative Journey Amid Tech Revolution (PR Newswire)
Feb-19-25 07:30AM	BGM Group Establishes 'Duxiaobao Management Committee' to Accelerate AI Strategy and Drive Intelligent Transformation in the Insurance Industry (PR Newswire)
Dec-27-24 09:30AM	BMG Completed Acquisition of High-Quality Assets, Marking a New Chapter in Diversified Growth (PR Newswire)
09:05AM	In-Depth Analysis of BGM Group: Innovating Pharmaceuticals and Insurance through AI (PR Newswire)
09:00AM	AIX Completes Strategic Share Exchange with BGM to Drive Growth in AI Insurance and Healthcare (GlobeNewswire)
Dec-19-24 08:30AM	BGM Group and Jointown Deepen Cooperation, Ushering in a New Era of Pharmaceutical Development (PR Newswire)
Nov-29-24 10:58AM	BGM Group Ltd Pioneers Innovation in AI Technology, Fostering Holistic Integration of Healthcare and Insurtech (PR Newswire) +22.50%
10:58AM	Loading…
10:58AM	/C O R R E C T I O N -- BGM Group Ltd/ (PR Newswire)
10:11AM	AIX Inc. (NASDAQ:AIFU): Reshaping AI Insurance and the Healthcare Industry--A Promising Future Ahead? (PR Newswire)
09:00AM	AIX and BGM Group Forge Strategic Deal, Leading Healthcare, Pharma, and Insurance Industry Expansion with AI (GlobeNewswire)
Nov-28-24 06:32AM	Qilian International Announces Major Share Subscription Deal (TipRanks)
Nov-22-24 08:30AM	BGM Group Welcomes Guilin Pharma for On-site Audit and Partnership Development (PR Newswire)
Oct-29-24 08:00AM	Qilian International Holding Group Limited Announces Name Change to BGM Group Ltd. (PR Newswire)
Aug-13-24 08:00AM	Qilian International Holding Group Ltd. Announces Trading Ticker Symbol to "BGM" (PR Newswire)

BGM Group Ltd. is a holding company, which engages in the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. It operates through the following segments: Oxytetracycline and Licorice Products, and Traditional Chinese Medicine Derivatives (TCMD); Heparin Products and Sausage Casing; and Fertilizer. The Oxytetracycline and Licorice Products, and TCMD segment focuses on the development, manufacture, marketing, and sale of oxytetracycline products, licorice products, and TCMD. The Heparin Products and Sausage Casing segment treats cardiovascular diseases, cerebrovascular diseases, and hemodialysis. The Fertilizer segment includes Xiongguan, Organic Fertilizer and Xiongguan, and Organic-Inorganic Compound Fertilizer. The company was founded on February 7, 2019 and is headquartered in Chengdu, China.

Co-Chief Executive Officer & DirectorMs. Huandi Zhao

Co-Chief Executive OfficerMs. Li Hong

Chief Financial OfficerMs. Yaxuan Zhai

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BGM Group Ltd

Upgrade your Finviz experience